Literature DB >> 4309239

Catecholamine-secreting paraganglioma of glomus-jugulare region resembling pheochromocytoma.

S A Levit, S G Sheps, R E Espinosa, W H Remine, E G Harrison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4309239     DOI: 10.1056/NEJM196910092811502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Familial malignant retroperitoneal paraganglioma.

Authors:  J P Sebastian; S E Williams; M Wells; M D Peake
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

2.  Current management of pheochromocytoma.

Authors:  W H Remine; G C Chong; J A Van Heerden; S G Sheps; E G Harrison
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

3.  Intracranial catecholamine secreting paragangliomas.

Authors:  M D Nelson; B E Kendall
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

4.  Catecholamine secreting tumor of the glomus jugulare.

Authors:  L Hens; C Plets; R Dom; L Velghe
Journal:  Klin Wochenschr       Date:  1979-07-15

5.  Noradrenalin-secreting retroperitoneal schwannoma resected by hand-assisted laparoscopic surgery: report of a case.

Authors:  Tomohide Hori; Kentaro Yamagiwa; Shintaro Yagi; Taku Iida; Kentaro Taniguchi; Chiduru Yamamoto; Yukitsuna Eshita; Yuji Kozuka; Haruyuki Takaki; Takuma Kato; Kanako Saito; Mie Torii; Syuji Isaji; Shinji Uemoto
Journal:  Surg Today       Date:  2006-12-25       Impact factor: 2.549

6.  Jugular body tumors: hyperplasias or true neoplasms? Light and electron microscopical investigations.

Authors:  D Stiller; D Katenkamp; K Küttner
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975

Review 7.  Paraganglioma of the nasal cavity: a case report.

Authors:  Sheyda Ketabchi; Daniela Massi; Roberto Santoro; Alessandro Franchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-01-21       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.